T1	Outcomes 153 168	LDL-cholesterol
T2	Outcomes 224 247	plasma triacylglycerol.
T3	Outcomes 351 374	triacylglycerol levels.
T4	Outcomes 1100 1155	plasma LDL-cholesterol, triacylglycerol and total ApoB.
T5	Outcomes 1186 1247	ApoB pool sizes of larger triacylglycerol-rich VLDL particles
T6	Outcomes 1268 1290	smaller VLDL particles
T7	Outcomes 1311 1343	intermediate density lipoprotein
T8	Outcomes 1447 1492	total fractional catabolic rate of VLDL1-ApoB
T9	Outcomes 1746 1786	production rates of VLDL2-, IDL- or LDL-
T10	Outcomes 1803 1829	VLDL1-ApoB production rate
T11	Outcomes 1894 1906	side effects
T12	Outcomes 2072 2091	LDL-ApoB catabolism
T13	Outcomes 2138 2185	catabolism of triacylglycerol-rich lipoproteins
T14	Outcomes 2222 2246	catabolism of VLDL1-ApoB
T15	Outcomes 2254 2264	VLDL2-ApoB
T16	Outcomes 2275 2283	IDL-ApoB
T17	Outcomes 2333 2343	VLDL1-ApoB
